Search results
Andrew Frankel
Job title: Consultant Nephrologist
Author
Mark E Cooper
Research Area(s) / Expertise:
Job title: Professor of Diabetes and head of the Department of Diabetes
Author
Microvascular Complications and Outcome after Drug-eluting Stent Implantation in Diabetic Patients
Author(s):
Carlo Briguori
,
Antonio Colombo
Added:
3 years ago
Article
Jas Gill
Job title: GP with Special Interest in Cardiology
Author
Linda Mellbin
Research Area(s) / Expertise:
Job title: Associate Professor of Cardiology
Author
Author(s):
Peter M Nilsson
Added:
3 years ago
Some cardiovascular (CV) risk-prone patients are easy to recognise, for example following manifestations of cardiovascular disease (CVD), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) interventions, and they deserve appropriate risk-factor control for secondary prevention, including blood pressure (BP) lowering. However, many other at-risk patients…
View more
Author(s):
Joanne D Schuijf
,
Jeroen J Bax
,
Ernst E van der Wall
Added:
3 years ago
Diabetes is an important risk factor for coronary artery disease (CAD) as reflected by the four-fold greater incidence of CAD in diabetic patients compared with the general population.1 Cardiovascular death is the most common cause of mortality in the type 2 diabetic population and, once diagnosed with CAD, patients with diabetes have a considerably poorer prognosis than their non-diabetic…
View more
Author(s):
Juan Carlos Kaski
,
Giuseppe Rosano
,
Theresa A McDonagh
,
et al
Start date:
Nov 05, 2020
View more
Author(s):
Kazeen Abdullah
,
Anand Rohatgi
Added:
3 years ago
Statins are currently the most efficacious and widely prescribed lipid-lowering medications.1 Numerous randomised controlled trials across a spectrum of baseline atherosclerotic cardiovascular disease (ASCVD) risk show that a 1.0 mmol/L (~40 mg/dL) reduction in low-density lipoprotein cholesterol (LDL-C) with statin therapy is associated with an overall 21 % reduction in major vascular events and…
View more
Author(s):
Gerasimos Filippatos
Added:
1 year ago
ESC Congress 22 — Prof Gerasimos Filippatos joins us onsite at ESC to discuss the findings of the FIDELITY study, which pooled the findings of FIDELIO-DKD and FIGARO-DKD to evaluate the impact of finerenonein addition to standard care in reducing the risk of cardiovascular and renal outcomes in adult patients with chronic kidney disease (CKD). Over 13,000 patients from 48 countries were included…
View more